Elite Pharmaceuticals Inc (ELTP)

[IB_]

"Is the CEO considering the development of a naltrexone-based antagonist ADF for CNS stimulants?": I am always thinking about our ADF antagonist and looking at all of our options.

"If so, what is the evidence that naltrexone can be used as an antagonist molecule for CNS stimulants?": No Answer

"Are there are any studies that can be cited that suggest this would be effective?": No Answer


"Are there any other drugs or experimental molecules that he is aware of that have shown this to be possible? What are they?": No Answer


..............................................

IB_